Skip to main content
S&P 5007,811.54+0.59%DOW51,654.95+0.83%NASDAQ27,366.17+0.64%BTC$82,516.00+0.84%ETH$2,488.45+0.36%GOLD$4,220.30+1.52%OIL$91.66+0.19%
Smart Investors Daily
SID Premium
EU

NASDAQ · EUDA

EUDA Health Holdings Limited

Healthcare · Medical - Healthcare Information Services

$18.48

Down-$0.12 (-0.67%)

Updated Oct 11, 2026, 6:48 PM

SID Score

5.3/10

Composite research score

Smart Money

—

Institutional and insider signal

Market cap
81.09M
P/E ratio
306.55
Dividend yield
0.00%
52-week range
$0.46 – $25.70
Volume
12.78K
Avg. volume
89.12K

Price performance · EUDA

EUDA price history

1M range · 20 trading sessions · Daily adjusted prices

Prices through Oct 9, 2026

EUDA closed at $18.48 after 20 trading sessions, up 11.56% for the selected period.

Last close
$18.48
Period change
+11.56%
Period low
$14.30
Period high
$19.39
Daily close
View OHLC price history
EUDA OHLC price history, latest 40 sessions
DateOpenHighLowCloseVolume
Oct 9, 2026$17.60$18.5994$17.57$18.47512.78K
Oct 8, 2026$18.44$19.4994$17.06$18.599436.21K
Oct 7, 2026$19.1251$20.1999$18.25$19.039410.44K
Oct 6, 2026$17.70$19.7654$17.105$19.3913.64K
Oct 5, 2026$17.29$17.8505$16.99$17.306.04K
Oct 2, 2026$15.98$17.29$15.70$17.236315.53K
Oct 1, 2026$14.5311$15.9194$14.2072$15.910413.55K
Sep 30, 2026$15.30$15.46$14.30$14.3012.34K
Sep 29, 2026$16.41$16.4732$15.9025$15.90255.44K
Sep 28, 2026$17.00$17.7413$16.20$16.208.51K
Sep 25, 2026$16.42$17.8615$16.42$17.861521.14K
Sep 24, 2026$17.48$17.48$16.42$16.4224.74K
Sep 23, 2026$16.20$18.03$16.20$17.3323.22K
Sep 22, 2026$18.00$18.10$16.6706$17.28521.49K
Sep 21, 2026$18.06$19.53$16.75$17.3827.97K
Sep 18, 2026$17.20$18.17$17.10$17.6230.72K
Sep 17, 2026$16.32$17.65$16.32$17.4220.99K
Sep 16, 2026$17.39$17.39$16.28$16.58522.3K
Sep 15, 2026$16.51$17.50$16.50$16.9514.49K
Sep 14, 2026$13.87$18.6599$13.87$16.5675.29K

Latest EUDA news

The latest Smart Investors Daily articles mentioning EUDA.

Stock researchCompany · Overview

EUDA research

Overview

Company profile and research snapshot.

Company profile

EUDA Health Holdings Ltd is a Singapore-based non-invasive healthcare provider in Asia with a focus on Singapore, Malaysia, and China. It offers inventive, accessible, and science-based health solutions to support the shift in regional healthcare from reactive medical treatment to proactive, longevity-focused care. The group also runs a Singapore-based property management business. It operates in two reportable segments: property management services and holistic wellness consumer products and services. Key revenue is generated from property management services that include management and security services for properties such as condominiums, residential apartments, business office buildings, and shopping malls.

Visit company website

Analyst outlook

Consensus and target data currently published for this company.

Consensus
Buy
Average target
$6.12
Implied upside
—
Analysts
7
EUDA recent ratings
DateFirmRatingTarget
Mar 9, 2026Greenridge GlobalBuy—
Open full forecast

News briefing

No generated briefing is available yet.

Yahoo · Aug 26, 2026

EUDA Health Subsidiary Melana International Wins SME100 Awards 2026 Singapore

SINGAPORE, AUGUST, Aug. 26, 2026 (GLOBE NEWSWIRE) -- EUDA Health Holdings Limited (NASDAQ: EUDA) (“EUDA” or the “Company”), a Singapore-based distributor of third-party wellness and non-invasive healthcare products and services in Singapore, Malaysia and China, as well as property management services in Singapore, today announced that its subsidiary, Melana International Pte. Ltd. (“Melana”), was recognised as one of the winners of the SME100 Awards 2026 Singapore, organised by Business Media In

Yahoo · Jan 7, 2026

EUDA Health Holdings Limited Announces Amendment to Streeterville Warrant Agreement

SINGAPORE, Jan. 07, 2026 (GLOBE NEWSWIRE) -- EUDA Health Holdings Limited (NASDAQ: EUDA) “EUDA” or “the Company”, a Singapore-based non-invasive healthcare provider in Asia focused on Singapore, Malaysia, and China, today announced that it has entered into an amendment (the “Warrant Amendment”) to its previously disclosed warrant agreement with Streeterville Capital, LLC (“Streeterville Capital”). Background on the Original Warrant Transaction As previously announced, on November 26, 2025, EUDA

Yahoo · Dec 30, 2025

EUDA Launches Nationwide Stem Cell Extraction, Cryostorage and Clinical Delivery Platform in China with Shenzhen Inno Immune and Wuhan Kaien Hospital

SINGAPORE, Dec. 30, 2025 (GLOBE NEWSWIRE) -- EUDA Health Holdings Limited (NASDAQ: EUDA) “EUDA” or “the Company,” a Singapore-based non-invasive healthcare provider in Asia focused on Singapore, Malaysia, and China, today announced the launch of its nationwide stem cell extraction, cryogenic storage and clinical delivery platform in China. The Company has partnered with Shenzhen Inno Immune Co., Ltd. and Wuhan Kaien Hospital as the Company continues to expand its national clinical and logistics

AI research layers

Interpretive context generated from the platform’s current data sources.

No results

AI research layers have not been published yet.

Featured By